Package 60505-5306-1

{"route": ["ORAL"], "spl_id": "99d0802e-98ae-2322-114d-9a06593c2dc7", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311", "197313"], "spl_set_id": ["7fdeb609-24c4-5024-52c3-6a32bc7f3fcc"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60505-5306-1)", "package_ndc": "60505-5306-1", "marketing_end_date": "20261231", "marketing_start_date": "20070609"}], "brand_name": "acyclovir", "product_id": "60505-5306_99d0802e-98ae-2322-114d-9a06593c2dc7", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "60505-5306", "generic_name": "acyclovir", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA077309", "marketing_category": "ANDA", "marketing_end_date": "20261231", "marketing_start_date": "20070609"}